Neuronetics, Inc.
$1.33
The Read: Neuronetics’ stock plunged about 45% after Q4 2025 earnings met EPS estimates but missed growth expectations, then surged nearly 134% following Q2 2026 results showing 86% revenue growth, positive cash flow, and new CEO appointment.
Price
Overlays
Panel
STIM
Hover to view data
No Data